NR 565 Pharm Midterm Exam Latest 2023 - 2024

Study Guides Aug 17, 2025
Loading...

Loading document viewer...

Page 0 of 0

Document Text

NR 565 Pharm Midterm Exam (Latest 2023 - 2024) New Full Questions and Answers ( Included ) 100% Correct

1. CYP2D6: Need to increase doses of SSRI, beta blockers etc. Codeine can be

deadly

2. CYP2C9: Decrease warfarin dose Test for

gene VCORC1 mutation

3. CYP3A4: Decreases elimination

Increase toxicity of Amio

  • Schedule I: no accepted medical use in the US it may not be prescribed. heroin, various
  • opium derivatives,hallucinogenic substances

5. Schedule II: No refills, no telephone orders Narcotics,

Stimulants, Depressants

  • Schedule III: Drugs in this category are considered to be at moderate or low risk for physical
  • dependence, and with current reasons for medical use Anabolic steroids, most barbituates and ketamine Must prescribe every 6 months, can be by phone

  • Schedule IV: Abuse potential exists, but less than Sch III. Examples are: Ambien, Darvocet and
  • Lorazepam

8. Schedule V: Not always necessary to have a prescription

Loperamide, diphenoxylate and cough medicine with less than 200mg/100 ml pregabalin

  • Preclinical research: Research of drug potential, animal testing, preparation for human testing
  • Phase I: Initial clinical safety studies in humans. May be as few as 10 subjects, often healthy
  • volunteers

  • Phase II: The study drug or treatment is given to a larger group of people (100-300) to see if
  • it is effective and to further evaluate its safety

  • Phase III: The study drug or treatment is given to large groups of people (1,000-3,000) to confirm
  • its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely

  • Phase IV: A study conducted after a drug has been shown to work and has been granted a license
  • (post-marketing surveillance study) 1 / 2

  • Adrenergic agonists: Drugs that stimulate and mimic the actions of the sympathetic nervous
  • system. Also called sympathomimetics.

  • alpha 2 agonists: Decrease sympathetic impulses from the CNS to the heart and arterioles,
  • causing vasodilation Lowers blood pressure, diuretic may be needed Clonodine, Methyldopa, Guanabenz

SE: dry mouth, urinary retention, weight gain etc.

  • Adrenergic Antagonist: A drug that blocks the actions of the sympathetic nervous system.

17. Alpha 1 Antagonist: Decreases arterial and venous vasoconstriction

Decreases blood pressure, helps relieve bph, Diuretic may be needed -osin

  • Beta adrenergic antagonists: drugs that block beta-adrenergic receptors; may be nonselective or
  • selective; also called beta blockers

  • Beta 1 Antagonist: Effects heart muscle, blocks receptors in SA node to de- crease hr, decrease
  • contractility

Reduces bp, reduces arrethymias, decreases angina incidences Metoprolol

20. Beta 2 antagonist: Lowers bp

Effects lungs, bronchial constriction, avoid in asthma patients

Propranolol

21. Propranolol Interactions: do not take with acetaminophin or warfarin

22. Propanolol other uses: Migraine prophylaxis, tremor, glaucoma

  • Beta Blocker teaching points: Monitor bp/hr so it's not too low report difficulty
  • breathing or wheezing

  • alpha and beta adrenergic antagonists: Lowers BP and reduces heart failure progression
  • / 2

Download Document

Buy This Document

$30.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: Study Guides
Added: Aug 17, 2025
Description:

NR 565 Pharm Midterm Exam (Latest 2023 - 2024) New Full Questions and Answers ( Included ) 100% Correct 1. CYP2D6: Need to increase doses of SSRI, beta blockers etc. Codeine can be deadly 2. CYP2C9...

Get this document $30.00